{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-018687","form_type":"8-K","ticker":"PALI","cik":"0001357459","company_name":"PALISADE BIO, INC.","filed_at":"2024-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.074921+00:00","generated_at":"2026-06-02T03:28:00.672671+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Palisade Bio appoints Margery Fischbein to Board of Directors","bullets":["Margery Fischbein appointed to the Board effective May 7, 2024; increases Board to 4 directors.","Determined independent per SEC and Nasdaq rules; appointed to Audit Committee.","Received option to purchase 1,000 shares at $7.90, vesting quarterly over 3 years.","Fischbein is Managing Director at Cassel Salpeter & Co.; previously headed healthcare investment banking at Seaport Global and FBR.","Press release issued May 7, 2024 announcing the appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-018687","json":"https://secwatch.observer/filing/0001493152-24-018687.json","markdown":"https://secwatch.observer/filing/0001493152-24-018687.md","text":"https://secwatch.observer/filing/0001493152-24-018687.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224018687/0001493152-24-018687-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224018687/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T03:28:00.672671+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"575814d984","claim":"Margery Fischbein was appointed as Director at PALISADE BIO, INC..","evidence_excerpt":"On May 7, 2024 (the “Effective Date”), the board of directors (“Board”) of Palisade Bio, Inc. (the “Company”) appointed Margery Fischbein to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224018687/0001493152-24-018687-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}